These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 289017)
21. [Real or alleged risks of clofibrate derivatives and certain risks of their prohibition]. de Gennes JL Nouv Presse Med; 1979 Mar; 8(15):1223-5. PubMed ID: 375186 [No Abstract] [Full Text] [Related]
22. Hypolipaemic drugs and coronary heart disease. Howard AN J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209 [No Abstract] [Full Text] [Related]
23. Does hypolipidemic therapy prevent coronary heart disease? Rifkind BM; Levy RI Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303 [No Abstract] [Full Text] [Related]
24. [Clofibrate and coronary disease]. Nikkilä E Duodecim; 1972; 88(10):684-7. PubMed ID: 5068883 [No Abstract] [Full Text] [Related]
25. [Anti-hyperlipemic therapy in the secondary prevention of coronary heart disease. Long-term study]. Caruzzo C Boll Soc Ital Cardiol; 1974; 19(6):503-15. PubMed ID: 4282709 [No Abstract] [Full Text] [Related]
26. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Miettinen M; Turpeinen O; Karvonen MJ Br Heart J; 1979 Sep; 42(3):370-1. PubMed ID: 508466 [No Abstract] [Full Text] [Related]
27. Confusion with clofibrate. Br Med J; 1972 Jun; 2(5813):547-8. PubMed ID: 5032774 [No Abstract] [Full Text] [Related]
28. Triglycerides and coronary heart disease. Bierman EL N Engl J Med; 1980 Oct; 303(18):1061. PubMed ID: 7421900 [No Abstract] [Full Text] [Related]
29. [Primary prevention of ischemic heart disease using clofibrate. Cooperative epidemiological study]. Geizerová H; Gyarfas I; Lamm G; Oliver M; Heady JA; Morris JN; Green K; Strasser T; Fejfar Z Cas Lek Cesk; 1979 Apr; 118(15):449-53. PubMed ID: 455361 [No Abstract] [Full Text] [Related]
30. The value of clofibrate. Hart A N Z Med J; 1978 Jun; 87(613):406. PubMed ID: 277806 [No Abstract] [Full Text] [Related]
32. [Critical review of clinical experimentation with clofibrate in coronary disease]. Azzena D; Astengo F Minerva Cardioangiol; 1973; 21(7):497-502. PubMed ID: 4756344 [No Abstract] [Full Text] [Related]
33. Five-year trial of clofibrate in ischaemic heart disease. Dewar HA Br Heart J; 1971 Jan; 33(1):145. PubMed ID: 5541898 [No Abstract] [Full Text] [Related]
34. [Results of a 5-year study of the action of clofibrate in the treatment of ischemic cardiopathy]. Dewar HA Minerva Med; 1971 Sep; 62(72):3456-7. PubMed ID: 5097216 [No Abstract] [Full Text] [Related]
36. Clofibrate in the management of hyperlipidaemia. Drug Ther Bull; 1982 May; 20(11):41-3. PubMed ID: 7140522 [No Abstract] [Full Text] [Related]
37. [Short-term pilot study of the feasibility of multifactor reduction of coronary risk]. Menotti A; Puddu V G Ital Cardiol; 1973; 3(2):206-19. PubMed ID: 4197329 [No Abstract] [Full Text] [Related]
38. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients]. Valiensi M; Riboli E; Lombardi M Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654 [No Abstract] [Full Text] [Related]
39. Effects of heparin and clofibrate on blood-serum lipid levels in patients with ischaemic heart disease. Haviar V; Riecanský L; Kusá O; Luknárová O Cor Vasa; 1972; 14(3):188-96. PubMed ID: 4344417 [No Abstract] [Full Text] [Related]